TCR2 Therapeutics
Why Robinhood?
You can watch TCRR and buy or sell other stocks, ETFs, and their options commission-free!About TCRR
TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development.
TCRR Key Statistics
Stock Snapshot
TCR2 Therapeutics(TCRR) stock is priced at $1.48, giving the company a market capitalization of 58.11M. It carries a P/E multiple of -0.35.
TCR2 Therapeutics(TCRR) stock opened on 2026-05-23 at —. The price climbed to — and dipped to —.
TCR2 Therapeutics(TCRR) shares are trading with a volume of 0, against a daily average of 694.31K.
During the past year, TCR2 Therapeutics(TCRR) stock moved between $0.82 at its lowest and $3.88 at its peak.
During the past year, TCR2 Therapeutics(TCRR) stock moved between $0.82 at its lowest and $3.88 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.